Target Name: ZFP62
NCBI ID: G643836
Review Report on ZFP62 Target / Biomarker Content of Review Report on ZFP62 Target / Biomarker
ZFP62
Other Name(s): ZFP62 zinc finger protein | ZNF755 | ZFP62 zinc finger protein, transcript variant 1 | zfp-62 | ZFP62_HUMAN | ZET | Zfp-62 | ZFP62 variant 1 | Zinc finger protein 62 homolog | Zinc finger protein 62 homolog (isoform 1)

ZFP62: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. One of the most well-studied ZFPs is ZFP62, which has been identified as a potential drug target and biomarker. In this article, we will provide an overview of ZFP62, its functions, and potential as a drug target and biomarker.

Structure and Expression

ZFP62 is a 21-kDa protein that contains 299 amino acid residues. It has a characteristic ZFP core structure, which consists of a N-terminal ZFP-specific domain, a C-terminal zinc finger domain, and a variable region (V-region) that includes 20 amino acid residues at its C-terminus. ZFP62 is expressed in various tissues and cells, including brain, heart, liver, and cancer cells. Its expression level is highly dependent on the cell type and developmental stage, and it is typically expressed in higher levels in tissues with higher levels of protein synthesis.

Function

ZFP62 is involved in various cellular processes, including cell adhesion, migration, and signaling. One of the most well-studied functions of ZFP62 is its role in cell adhesion. ZFP62 has been shown to be involved in the regulation of tight junction formation and cell-cell adhesion, which are critical for various physiological processes, including tissue repair and regeneration.

In addition to its role in cell adhesion, ZFP62 is also involved in the regulation of cell migration. It has been shown to be involved in the regulation of cell migration, which is critical for the development and progression of various diseases, including cancer. ZFP62 has been shown to play a role in the regulation of cell cycle progression, and its expression level is often associated with the growth and survival of cancer cells.

Potential Drug Target

ZFP62 has been identified as a potential drug target due to its unique structure and function. One of the key reasons for its potential as a drug target is its ability to interact with various signaling pathways, including TGF-β, Wnt, and NF-kappa-B signaling pathways. ZFP62 has been shown to play a role in the regulation of these signaling pathways, and its expression level is often associated with the development and progression of various diseases.

In addition to its potential as a drug target, ZFP62 has also been identified as a potential biomarker. Its expression level is often affected by various factors, including stress, chemokines, and hormones. ZFP62 has been shown to play a role in the regulation of stress response and inflammation, and its expression level is often associated with the development and progression of various diseases, including cancer.

Conclusion

ZFP62 is a protein that has been well-studied for its role in various cellular processes, including cell adhesion, migration, and signaling. Its unique structure and function make it a potential drug target and biomarker. Further research is needed to fully understand the role of ZFP62 in various biological processes and its potential as a drug target and biomarker.

Protein Name: ZFP62 Zinc Finger Protein

Functions: May play a role in differentiating skeletal muscle

The "ZFP62 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZFP62 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZFP64 | ZFP64P1 | ZFP69 | ZFP69B | ZFP82 | ZFP90 | ZFP91 | ZFP91-CNTF | ZFP92 | ZFPL1 | ZFPM1 | ZFPM2 | ZFPM2-AS1 | ZFR | ZFR2 | ZFTA | ZFTRAF1 | ZFX | ZFX-AS1 | ZFY | ZFYVE1 | ZFYVE16 | ZFYVE19 | ZFYVE21 | ZFYVE26 | ZFYVE27 | ZFYVE28 | ZFYVE9 | ZFYVE9P1 | ZG16 | ZG16B | ZGLP1 | ZGPAT | ZGRF1 | ZHX1 | ZHX1-C8orf76 | ZHX2 | ZHX3 | ZIC1 | ZIC2 | ZIC3 | ZIC4 | ZIC5 | ZIK1 | ZIM2 | ZIM3 | Zinc finger protein GLI | ZKSCAN1 | ZKSCAN2 | ZKSCAN3 | ZKSCAN4 | ZKSCAN5 | ZKSCAN7 | ZKSCAN8 | ZKSCAN8P1 | ZMAT1 | ZMAT2 | ZMAT3 | ZMAT4 | ZMAT5 | ZMIZ1 | ZMIZ1-AS1 | ZMIZ2 | ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142